Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells ; volume:10 ; number:1 ; day:26 ; month:4 ; year:2017 ; pages:1-12 ; date:12.2017
Journal of ovarian research ; 10, Heft 1 (26.4.2017), 1-12, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Thibault, Benoît
- Beteiligte Personen und Organisationen
-
Jean-Claude, Bertrand
SpringerLink (Online service)
- DOI
-
10.1186/s13048-017-0319-2
- URN
-
urn:nbn:de:1111-201705085531
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thibault, Benoît
- Jean-Claude, Bertrand
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evaluation of antioxidant and anti-inflammatory potency of Lepidium pinnatifidum Ledeb
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Expressionsveränderung zellulärer Promotionsfaktoren durch die Proteinkinaseinhibitoren Erlotinib, Gefitinib, Dasatinib, Everolimus und Nilotinib in humanen Plattenepithelkarzinomzellen in vitro
Targeting Macrophages and Synoviocytes Intracellular Milieu to Augment Anti‐Inflammatory Drug Potency
CYP3A4-mediated metabolism of artemisinin to 10β-hydroxyartemisinin with comparable anti-malarial potency
Evaluation of anti-malarial potency of new pyrazole-hydrazine coupled to Schiff base derivatives
Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion
Dasatinib—A Generation Ahead
Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coatingGefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating
Comparison of the immunomodulatory potential of platinum-based anti-cancer drugs and anthracyclins on human monocyte-derived cells
ANTI-ANTiFA
ANTi ANtiFA
Evaluation of antioxidant and anti-inflammatory potency of Lepidium pinnatifidum Ledeb
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Expressionsveränderung zellulärer Promotionsfaktoren durch die Proteinkinaseinhibitoren Erlotinib, Gefitinib, Dasatinib, Everolimus und Nilotinib in humanen Plattenepithelkarzinomzellen in vitro
Targeting Macrophages and Synoviocytes Intracellular Milieu to Augment Anti‐Inflammatory Drug Potency
CYP3A4-mediated metabolism of artemisinin to 10β-hydroxyartemisinin with comparable anti-malarial potency
Evaluation of anti-malarial potency of new pyrazole-hydrazine coupled to Schiff base derivatives
Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion
Dasatinib—A Generation Ahead
Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coatingGefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating
Comparison of the immunomodulatory potential of platinum-based anti-cancer drugs and anthracyclins on human monocyte-derived cells
ANTI-ANTiFA
ANTi ANtiFA
Evaluation of antioxidant and anti-inflammatory potency of Lepidium pinnatifidum Ledeb
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Expressionsveränderung zellulärer Promotionsfaktoren durch die Proteinkinaseinhibitoren Erlotinib, Gefitinib, Dasatinib, Everolimus und Nilotinib in humanen Plattenepithelkarzinomzellen in vitro
Targeting Macrophages and Synoviocytes Intracellular Milieu to Augment Anti‐Inflammatory Drug Potency
CYP3A4-mediated metabolism of artemisinin to 10β-hydroxyartemisinin with comparable anti-malarial potency
Evaluation of anti-malarial potency of new pyrazole-hydrazine coupled to Schiff base derivatives
Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion
Dasatinib—A Generation Ahead
Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coatingGefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating
Comparison of the immunomodulatory potential of platinum-based anti-cancer drugs and anthracyclins on human monocyte-derived cells
ANTI-ANTiFA